Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Chemotherapy × Oxaliplatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 362 Stomach Neoplasms 252 Rectal Neoplasms 238 Colonic Neoplasms 169 Pancreatic Neoplasms 142 Neoplasm Metastasis 89 Esophageal Neoplasms 76 Neoplasms 57 Carcinoma, Hepatocellular 50 Adenocarcinoma Of Esophagus 42 Adenocarcinoma 42 Lymphoma, Large B-Cell, Diffuse 40 Cholangiocarcinoma 40 Carcinoma, Non-Small-Cell Lung 33 Biliary Tract Neoplasms 30 Gallbladder Neoplasms 26 Gastrointestinal Neoplasms 24 Recurrence 23 Liver Neoplasms 22 Esophageal Squamous Cell Carcinoma 20 Breast Neoplasms 20 Ovarian Neoplasms 17 Bile Duct Neoplasms 17 Unspecified Adult Solid Tumor, Protocol Specific 13 Peritoneal Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Lung Neoplasms 10 Head and Neck Neoplasms 10 Colorectal Cancer Metastatic 10 Appendiceal Neoplasms 10

Interventions

irinotecan sucrosofate 1 Oxaliplatin 1 Neoadjuvant Therapy 1 Fluorouracil 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06172036 2023-12-15

CAPT-02

Zhejiang University

Phase 2 Not yet recruiting

Gastrointestinal

Neoadjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡